Catabolic and inflammatory pathways in chondrocytes

Catabolic and inflammatory pathways in chondrocytes represent a complex network of signaling events that lead to the degradation of articular cartilage, primarily seen in conditions like osteoarthritis. Under pathological stress, chondrocytes shift from a homeostatic anabolic state to a catabolic phenotype, driven by pro-inflammatory cytokines such as Interleukin-1 beta (IL-1β) and Tumor Necrosis Factor alpha (TNF-α). These cytokines activate intracellular signaling mediators, including NF-κB and Mitogen-Activated Protein Kinases (MAPKs), which trigger the expression of matrix-degrading enzymes like MMP-13 and ADAMTS-5. This process results in the breakdown of type II collagen and proteoglycans, the structural pillars of the cartilage extracellular matrix. Therapeutic strategies often focus on inhibiting these specific inflammatory mediators or their downstream effectors to slow disease progression and preserve joint function.

Other names

Chondrocyte catabolic signalingInflammatory pathways in articular cartilageCartilage degradation pathwaysOA-related signaling in chondrocytes

Inhibition of pro-inflammatory cytokine signaling (e.g., IL-1, TNF-alpha), suppression of matrix-degrading enzymes (MMPs, ADAMTS), and modulation of intracellular signaling cascades like NF-kappaB and MAPK to restore homeostatic balance in the cartilage matrix.